+91-8668442535

Diabetic Retinopathy Market By Device Type (Focal Laser Treatment, Scatter Laser Treatment, Vitrectomy Devices), Drug Type (Aflibercept, Bevacizumab,Fluocinolone, Acetonide, Ranibizumab, Triamcinolone Acetonide) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Diabetic retinopathy is among the leading causes of legal blindness among the working-age adults worldwide. Anticipated increase in prevalence of diabetes prevalence indicates that diabetic retinopathy will continue to the prevalence of vision loss in the future. Diabetes and diabetes related complications carry heavy economic burden. Estimates also suggest that diabetic retinopathy alone contributes 10% to 42% of direct medical costs, whereas the indirect costs could be much higher. Surgical treatments have been preferred for a long time for diabetic retinopathy treatment at severe stages. Several pharmacological treatments are introduced and many are in development for treating this complication. This report studies the global and regional markets for various diabetic retinopathy treatments currently available.

For the purpose of this study, the global diabetic retinopathy market is assessed for diabetic retinopathy treatment devices and drugs. The devices market is categorized into focal laser treatment, scatter laser treatment and vitrectomy devices. the diabetic retinopathy treatment drugs is studied for aflibercept (Eylea), bevacizumab (Avastin), fluocinolone acetonide (Iluvien), ranibizumab (Lucentis) and triamcinolone acetonide. Global market size and forecast for the mentioned segments for the period 2014-2022 along with corresponding CAGRs for the forecast period 2016-2022 are included in this section.

Geographically, the global diabetic retinopathy market is studied for the following regional markets:

North America

a.    U.S.

b.    Canada

Europe

a.    U.K.

b.    Germany

c.    Rest of Europe

Asia-Pacific

a.    Japan

b.    China

c.    Rest of Asia-Pacific

Middle East and Africa

Latin America

The market size and forecast for the period 2014-2022 along with the CAGRs for the period 2016-2022 for the mentioned segments are also presented in this study.

Qualitative information sets such as market dynamics (drivers, challenges, future prospects) and market inclination insights are provided in this market assessment report. Tools such as competition assessment and attractive investment proposition are also included in this study for studying the global market competition. The report concludes with company profiles section that highlights key information about the major market players operating in the global diabetic retinopathy market.

Diabetic Retinopathy Market

Choose License Type
Trusted By
Godaddy
Related Report










Published Date:  Jun 2016
Category:  Medical Devices
Report ID:   57942
Report Format:   PDF
Pages:   120
Rating:    4.2 (50)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support